The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
we've just completed another study where we don't observe an increase in HDL in what I call teeny boppers people who are under 30 and we did a whole trial in uh in young people that we've never looked at we've never looked at that age group before and we don't see the same increase that we see in people who are a little older
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
there was a study that you guys all published together a few years ago in 2012 that was done in lean people and so maybe we can talk a little bit about what those results were well the primary effect these weren't all lean people they were it was a range but they were mostly at the lower end so they were and they were also tended to be adults middle aged people so they weren't kids and the the primary result that we found in that was a strong rise in HDL and particularly um Mark might want to talk about the particles do you want to talk about the hdl2b and and why it's so significant that the rise that we saw was almost exclusively with a particle called hdl2b